Feedback / Questions
LISPRO (lithium/proline/salicylate) - Alzamend Neuro
https://www.businesswire.com/news/home/20230322005380/en/Alzamend-Neuro-Announces-Completion-of-Clinical-Portion-of-Phase-IIA-Multiple-Ascending-Dose-Clinical-Trial-for-AL001-Treatment-of-Dementia-Related-to-Alzheimer%E2%80%99s
Mar 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next